ATE359294T1 - Toxinrezeptoren aus zonula occludens - Google Patents

Toxinrezeptoren aus zonula occludens

Info

Publication number
ATE359294T1
ATE359294T1 AT98904957T AT98904957T ATE359294T1 AT E359294 T1 ATE359294 T1 AT E359294T1 AT 98904957 T AT98904957 T AT 98904957T AT 98904957 T AT98904957 T AT 98904957T AT E359294 T1 ATE359294 T1 AT E359294T1
Authority
AT
Austria
Prior art keywords
zonula occludens
toxin receptors
receptors
toxin
zonula
Prior art date
Application number
AT98904957T
Other languages
German (de)
English (en)
Inventor
Alessio Fasano
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/803,364 external-priority patent/US5864014A/en
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE359294T1 publication Critical patent/ATE359294T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/909—Vibrio
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98904957T 1997-02-20 1998-02-18 Toxinrezeptoren aus zonula occludens ATE359294T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/803,364 US5864014A (en) 1997-02-20 1997-02-20 Zonula occludens toxin receptor
US09/024,198 US5912323A (en) 1997-02-20 1998-02-17 Zonula occludens toxin receptors

Publications (1)

Publication Number Publication Date
ATE359294T1 true ATE359294T1 (de) 2007-05-15

Family

ID=26698164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98904957T ATE359294T1 (de) 1997-02-20 1998-02-18 Toxinrezeptoren aus zonula occludens

Country Status (9)

Country Link
US (2) US5912323A (enExample)
EP (1) EP1007553B1 (enExample)
JP (1) JP4215827B2 (enExample)
AT (1) ATE359294T1 (enExample)
AU (1) AU6270298A (enExample)
CA (1) CA2281617A1 (enExample)
DE (1) DE69837546T2 (enExample)
ES (1) ES2285762T3 (enExample)
WO (1) WO1998037096A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458925B1 (en) * 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
EP1249244A1 (en) 2001-04-13 2002-10-16 Universiteit Gent Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease
JP2005526772A (ja) * 2002-03-15 2005-09-08 リテック 消化機能病理を処置するための組成物
FR2844201A1 (fr) * 2002-09-06 2004-03-12 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
DE60334923D1 (de) 2002-09-06 2010-12-23 Promega Corp Tät
US7741067B2 (en) 2002-12-23 2010-06-22 Promega Corporation Luciferase-based assays
JP2007534621A (ja) * 2003-07-15 2007-11-29 ユニバーシティ オブ メリーランド， ボルチモア Ｚｏｔおよびゾニューリンに対するレセプターのアゴニストペプチド
US20080038843A1 (en) * 2006-08-11 2008-02-14 University Of Maryland - Baltimore Method of diagnosing celiac disease
CA2614068A1 (en) * 2004-06-29 2006-08-24 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
AR053661A1 (es) * 2005-01-14 2007-05-16 Univ Maryland Peptido para entregar vacunas via mucosas
AR057058A1 (es) * 2005-06-09 2007-11-14 Alba Therapeutics Corp Metodo para usar antagonistas de zonulina para prevenir la perdida o para regenerar celulas pancreaticas
BRPI0707616A2 (pt) * 2006-02-09 2011-05-10 Alba Therapuetics Corp formulaÇÕes para um efetor de junÇço oclusiva
US20090069247A1 (en) * 2006-10-06 2009-03-12 Blake Paterson Use of tight junction antagonists to treat inflammatory bowel disease
US8034776B2 (en) * 2006-10-26 2011-10-11 Alba Therapeutics Corporation Materials and methods for the treatment of celiac disease
WO2008073627A2 (en) 2006-11-03 2008-06-19 Alba Therapeutics Corporation Method of diagnosing and treating asthma
US8728491B2 (en) * 2007-05-07 2014-05-20 Alba Therapeutics Corporation Transcutaneous delivery of therapeutic agents
US20110201543A1 (en) * 2007-06-29 2011-08-18 Blake Paterson Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress
WO2009015382A2 (en) 2007-07-26 2009-01-29 Alba Therapeutics Corporation Novel peptides that enhance tight junction permeability

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216126A (en) * 1991-06-19 1993-06-01 Genentech, Inc. Receptor polypeptides and their production and uses
US5665389A (en) * 1995-05-24 1997-09-09 University Of Maryland At Baltimore Oral dosage composition for intestinal delivery and method of treating diabetes

Also Published As

Publication number Publication date
EP1007553B1 (en) 2007-04-11
US5948629A (en) 1999-09-07
US5912323A (en) 1999-06-15
WO1998037096A1 (en) 1998-08-27
CA2281617A1 (en) 1998-08-27
DE69837546D1 (de) 2007-05-24
DE69837546T2 (de) 2007-12-27
ES2285762T3 (es) 2007-11-16
EP1007553A1 (en) 2000-06-14
JP4215827B2 (ja) 2009-01-28
JP2001518077A (ja) 2001-10-09
EP1007553A4 (en) 2004-09-22
AU6270298A (en) 1998-09-09

Similar Documents

Publication Publication Date Title
DE69837546D1 (de) Toxinrezeptoren aus zonula occludens
DE69737592D1 (de) Mittel gegen juckreiz
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
BR0112701B1 (pt) retentor de aba cranial.
ID29552A (id) Senyawa-senyawa triazola dan penggunaannya
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
ATE264863T1 (de) 28-epirapaloge
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
ATE314371T1 (de) Spiro-indole als y5-rezeptor antagonisten
DK1200418T3 (da) Nematodicide trifluorbutener
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
MXPA02001719A (es) METODOS, COMPOSICIONES Y EQUIPOS PARA PROMOVER LA RECUPERACION DEL DAnO AL SISTEMA NERVIOSO CENTRAL.
DE69906938D1 (de) Glococorticoid selektive entzündungshemmende mittel
DE69823493D1 (de) Tetrahydropyridoverbindungen
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
WO2001030330A3 (en) Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
DK1144666T3 (da) Replikationsdeficient baculovirusekspressionssystem
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
SE9803107D0 (sv) Novel Compunds
TR199902914T2 (xx) �zole sistolik hipertansiyonu tedavi y�ntemi.
IT239134Y1 (it) Dispositivo aspirante, particolarmente per w.c.
ITBO970065A0 (it) Dispositivo per la formazione di gruppi di sigarette.
ITRE20020101A1 (it) Sistema per la produzione di idrogeno da idrocarburi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties